Elastases degrade the extracellular matrix, releasing growth factors and chemotactic peptides, inducing glycoproteins such as tenascin, and thereby promoting vascular cell proliferation and migration. Administration of serine elastase inhibitors reduces experimentally induced vascular disease. The ability to mount an intrinsic anti-elastase response may, therefore, protect against intimal/medial thickening after vascular injury. To investigate this, we showed that wire-induced endothelial denudation of the carotid artery is associated with transient elevation in elastase activity and confirmed that this is abolished in transgenic mice overexpressing the serine elastase inhibitor, elafin, targeted to the cardiovascular system. Ten days after injury, nontransgenic littermates show vessel enlargement, intimal thickening, increased medial area and cellularity, and 2-fold increase in tenascin. Injured vessels in transgenic mice become enlarged but are otherwise similar to sham-operated controls. Injury-induced vessel wall thickening, which is observed only in nontransgenic mice, is related to foci of neutrophils and macrophages, in addition to smooth muscle cells that fail to stain for α-actin and are likely dedifferentiated. Our study therefore suggests that a major determinant of the vascular response to injury is the early transient induction of serine elastase activity, which leads to cellular proliferation and inflammatory cell migration.
Syed H.E. Zaidi, Xiao-Mang You, Sorana Ciura, Stacey O’Blenes, Mansoor Husain, Marlene Rabinovitch
Title and authors | Publication | Year |
---|---|---|
Phosphorylation of USP20 on Ser334 by IRAK1 promotes IL-1β-evoked signaling in vascular smooth muscle cells and vascular inflammation
Zhang L, Wu JH, Jean-Charles PY, Murali P, Zhang W, Jazic A, Kaur S, Nepliouev I, Stiber JA, Snow K, Freedman NJ, Shenoy SK |
The Journal of biological chemistry | 2023 |
New and Emerging Therapies for Pulmonary Arterial Hypertension
E Spiekerkoetter, SM Kawut, VA de Jesus Perez |
Annual Review of Medicine | 2019 |
BMP type II receptor as a therapeutic target in pulmonary arterial hypertension
M Orriols, MC Gomez-Puerto, P Dijke |
Cellular and Molecular Life Sciences | 2017 |
Matrix ageing and vascular impacts: focus on elastin fragmentation
L Duca, S Blaise, B Romier, M Laffargue, S Gayral, HE Btaouri, C Kawecki, A Guillot, L Martiny, L Debelle, P Maurice |
Cardiovascular Research | 2016 |
Perioperative elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: a randomised-controlled trial
SR Alam, SC Lewis, V Zamvar, R Pessotto, MR Dweck, A Krishan, K Goodman, K Oatey, R Harkess, L Milne, S Thomas, NM Mills, C Moore, S Semple, O Wiedow, C Stirrat, S Mirsadraee, DE Newby, PA Henriksen |
Heart (British Cardiac Society) | 2015 |
WFDC1 Is a Key Modulator of Inflammatory and Wound Repair Responses
SJ Ressler, TD Dang, SM Wu, DY Tse, BE Gilbert, A Vyakarnam, F Yang, IG Schauer, DA Barron, DR Rowley |
The American Journal of Pathology | 2014 |
Gene expression profiling on the molecular action of danshen-gegen formula in a randomized placebo-controlled trial of postmenopausal women with hypercholesterolemia
CM Koon, CH Ko, XX Sun, SW Hoi, JC Tam, DW Cheung, KF Cheng, SY Pang, WM Lo, P Chook, CB Lau, WY Chan, PC Leung, TC Kwok, KP Fung |
Evidence-Based Complementary and Alternative Medicine | 2013 |
Neonatal mice genetically modified to express the elastase inhibitor elafin are protected against the adverse effects of mechanical ventilation on lung growth
A Hilgendorff, K Parai, R Ertsey, GJ Rey-Parra, B Thébaud, R Tamosiuniene, N Jain, EF Navarro, BC Starcher, MR Nicolls, M Rabinovitch, RD Bland |
American journal of physiology. Lung cellular and molecular physiology | 2012 |
Whey acidic proteins (WAPs) : novel modulators of innate immunity to HIV infection
JL Reading, AF Meyers, A Vyakarnam |
Current Opinion in HIV and AIDS | 2012 |
Neonatal mice genetically modified to express the elastase inhibitor elafin are protected against the adverse effects of mechanical ventilation on lung growth
A Hilgendorff, K Parai, R Ertsey, GJ Rey-Parra, B Thébaud, R Tamosiuniene, N Jain, EF Navarro, BC Starcher, MR Nicolls, M Rabinovitch, RD Bland |
American journal of physiology. Lung cellular and molecular physiology | 2012 |
Inhibiting Lung Elastase Activity Enables Lung Growth in Mechanically Ventilated Newborn Mice
A Hilgendorff, K Parai, R Ertsey, N Jain, EF Navarro, JL Peterson, R Tamosiuniene, MR Nicolls, BC Starcher, M Rabinovitch, RD Bland |
American journal of respiratory and critical care medicine | 2011 |
AMPKα2 Deletion Exacerbates Neointima Formation by Upregulating Skp2 in Vascular Smooth Muscle Cells
P Song, S Wang, C He, S Wang, B Liang, B Viollet, MH Zou |
Circulation research | 2011 |
Neutrophil Elastase Is Produced by Pulmonary Artery Smooth Muscle Cells and Is Linked to Neointimal Lesions
YM Kim, L Haghighat, E Spiekerkoetter, H Sawada, CM Alvira, L Wang, S Acharya, G Rodriguez-Colon, A Orton, M Zhao, M Rabinovitch |
The American Journal of Pathology | 2011 |
Role Of The Endogenous Elastase Inhibitor, Elafin, In Cardiovascular Injury From Epithelium To Endothelium
SR Alam, DE Newby, PA Henriksen |
Biochemical Pharmacology | 2011 |
Therapeutic potential of human elafin
L Shaw, O Wiedow |
Biochemical Society Transactions | 2011 |
Evolution of trappin genes in mammals
A Kato, AP Rooney, Y Furutani, S Hirose |
BMC Evolutionary Biology | 2010 |
Extracellular Matrix Degradation Products and Low-Oxygen Conditions Enhance the Regenerative Potential of Perivascular Stem Cells
S Tottey, M Corselli, EM Jeffries, R Londono, B Peault, SF Badylak |
Tissue Engineering Part A | 2010 |
Textbook of Pulmonary Vascular Disease
, JG Garcia, JB West, CA Hales, S Rich, SL Archer |
2010 | |
Elafin (SKALP/Trappin-2/proteinase inhibitor-3) Is Produced by the Cervix in Pregnancy and Cervicovaginal Levels Are Diminished in Bacterial Vaginosis
SJ Stock, L Duthie, T Tremaine, AA Calder, RW Kelly, SC Riley |
Reproductive sciences (Thousand Oaks, Calif.) | 2009 |
Congenital Diseases in the Right Heart
AN Redington, GS Arsdell, RH Anderson |
2009 | |
Integration of Flow-Dependent Endothelial Phenotypes by KLF2
Kush M. Parmar, H. Benjamin Larman, Guohao Dai, Yuzhi Zhang, Eric T. Wang, Sripriya N. Moorthi, Johannes R. Kratz, Zhiyong Lin, Mukesh Jain, Michael A. Gimbrone, Jr., and Guillermo García-Cardeña |
Journal of Clinical Investigation | 2006 |
Expression profiles of elastase1 (NvElastaseI) and secretory leukocyte protease inhibitor (NvSLPI) during forelimb regeneration in adult Notophthalmus viridescens suggest a role in epithelial remodeling and delamination
SG Vascotto, S Beug, RA Liversage, C Tsilfidis |
Development Genes and Evolution | 2006 |
Increased local levels of granulocyte colony-stimulating factor are associated with the beneficial effect of pre-elafin (SKALP/trappin-2/WAP3) in experimental emphysema
MF Janelle, A Doucet, D Bouchard, Y Bourbonnais, GM Tremblay |
Biological Chemistry | 2006 |
1-Antitrypsin Gene Therapy Modulates Cellular Immunity and Efficiently Prevents Type 1 Diabetes in Nonobese Diabetic Mice
Y Lu, M Tang, C Wasserfall, Z Kou, M Campbell-Thompson, T Gardemann, J Crawford, M Atkinson, S Song |
Human Gene Therapy | 2006 |
α1-Antitrypsin Gene Therapy Modulates Cellular Immunity and Efficiently Prevents Type 1 Diabetes in Nonobese Diabetic Mice
Y Lu, M Tang, C Wasserfall, Z Kou, M Campbell-Thompson, T Gardemann, J Crawford, M Atkinson, S Song |
Human Gene Therapy | 2006 |
Identification of cDNAs associated with late dedifferentiation in adult newt forelimb regeneration
SG Vascotto, S Beug, RA Liversage, C Tsilfidis |
Developmental Dynamics | 2005 |
Elafin-overexpressing mice have improved cardiac function after myocardial infarction
K Ohta |
American journal of physiology. Heart and circulatory physiology | 2004 |
Conditional expression of a dominant-negative c-Myb in vascular smooth muscle cells inhibits arterial remodeling after injury
XM You, IN Mungrue, W Kalair, T Afroze, B Ravi, AM Sadi, R Gros, M Husain |
Circulation research | 2003 |
Angiogenesis and Pulmonary Hypertension: A Unique Process in a Unique Disease
RM Tuder, NF Voelkel |
Antioxidants & Redox Signaling | 2002 |
Wiley Encyclopedia of Molecular Medicine
WT Morgan |
Wiley Encyclopedia of Molecular Medicine | 2002 |
pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque
M Naghavi, R John, S Naguib, MS Siadaty, R Grasu, KC Kurian, WB Winkle, B Soller, S Litovsky, M Madjid, JT Willerson, W Casscells |
Atherosclerosis | 2002 |
Anti-Inflammatory Effect of Pre-Elafin in Lipopolysaccharide-Induced Acute Lung Inflammation
E Vachon, Y Bourbonnais, CD Bingle, SJ Rowe, MF Janelle, GM Tremblay |
Biological Chemistry | 2002 |
A critical role for elastin signaling in vascular morphogenesis and disease
SK Karnik, BS Brooke, A Bayes-Genis, L Sorensen, JD Wythe, RS Schwartz, MT Keating, DY Li |
Development (Cambridge, England) | 2002 |
Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension
SH Zaidi, XM You, S Ciura, M Husain, M Rabinovitch |
Circulation | 2002 |
Future Research Directions in Chronic Obstructive Pulmonary Disease
TL Croxton, GG Weinmann, Robert M., JR Hoidal |
American journal of respiratory and critical care medicine | 2002 |
Gene Expression Profiles of Genistein-Treated PC3 Prostate Cancer Cells
Y Li, FH Sarkar |
The Journal of nutrition | 2002 |
Arterial Elastase Activity After Balloon Angioplasty and Effects of Elafin, an Elastase Inhibitor
AW Barolet, N Nili, A Cheema, R Robinson, MK Natarajan, S OBlenes, J Li, MR Eskandarian, J Sparkes, M Rabinovitch, BH Strauss |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |
Cardiovascular Physiology in the Genetically Engineered Mouse
BD Hoit, RA Walsh |
2001 |